참고문헌
- Airoldi M, Gabriele AM, Garzaro M, et al (2009). Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population. Radiother Oncol, 92, 105-10. https://doi.org/10.1016/j.radonc.2009.02.005
- Airoldi M, Gabriele P, Gabriele AM, et al (2011). Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin+taxol in locally advanced nasopharyngeal carcinoma. Cancer Chemother Pharmacol, 67, 1027-34. https://doi.org/10.1007/s00280-010-1399-5
- Al-Amro A, Al-Rajhi N, Khafaga Y, et al (2005). Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 62, 508. https://doi.org/10.1016/j.ijrobp.2004.09.050
- Bae WK, Hwang JE, Shim HJ, et al (2010). Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Cancer Chemother Pharmacol, 65, 589-95 https://doi.org/10.1007/s00280-009-1152-0
- Baujat B, Audry H, Bourhis J, et al (2006). Chemotherapy in locally advanced nasopharyngeal carcinoma, an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys, 64, 47. https://doi.org/10.1016/j.ijrobp.2005.06.037
- Bossi P, Orlandi E, Bergamini C, et al (2011). Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer. Ann Oncol, 22, 2495-500 https://doi.org/10.1093/annonc/mdq783
- Chan AT, Teo PM, Huang DP, et al (2004). Pathogenesis and treatment of nasopharyngeal carcinoma. Semin Oncol, 31, 794. https://doi.org/10.1053/j.seminoncol.2004.09.008
- Chua DT, Sham JS, Choy D, et al (1998). Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. asian-oceanian clinical oncology association nasopharynx cancer study group. Cancer, 83, 2270. https://doi.org/10.1002/(SICI)1097-0142(19981201)83:11<2270::AID-CNCR6>3.0.CO;2-T
- Chua DT, Ma J, Sham JS, et al (2005). Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma, a pooled data analysis of two phase III trials. J Clin Oncol, 23, 1118 https://doi.org/10.1200/JCO.2005.12.081
- Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours, revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228. https://doi.org/10.1016/j.ejca.2008.10.026
- Ekenel M, Keskin S, Basaran M, et al (2011). Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma. Oral Oncol, 47, 660-4. https://doi.org/10.1016/j.oraloncology.2011.04.010
- Fountzilas G, Ciuleanu E, Bobos M, et al (2012). Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma, a randomized phase II study conducted by the hellenic cooperative oncology group (HeCOG) with biomarker evaluation. Ann Oncol, 23, 427-435. https://doi.org/10.1093/annonc/mdr116
- Hareyama M, Sakata K, Shirato H, et al (2002). A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer, 94, 2217-23. https://doi.org/10.1002/cncr.10473
- Hui EP, Ma BB, Chan AT, et al (2009) . Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol, 27, 242-9. https://doi.org/10.1200/JCO.2008.18.1545
- Jamshed A, Hussain R, Iqbal H (2014). Gemcitabine and cisplatin followed by chemo-radiation for advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 899-904. https://doi.org/10.7314/APJCP.2014.15.2.899
- Kong L, Zhang YW, Hu CS, et al (2010). Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma. Chin J Cancer, 29, 551-5. https://doi.org/10.5732/cjc.009.10518
- Langendijk JA, Leemans CR, Buter J, et al (2004). The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma, a meta-analysis of the published literature. J Clin Oncol, 22, 4604. https://doi.org/10.1200/JCO.2004.10.074
- Lee AW, Sze WM, Au JS, et al (2005). Treatment results for nasopharyngeal carcinoma in the modern era, the Hong Kong experience. Int J Radiat Oncol Biol Phys, 61, 1107. https://doi.org/10.1016/j.ijrobp.2004.07.702
- Lee AW, Lau KY, Hung WM, et al (2008). Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma. Radiother Oncol, 87, 204-10. https://doi.org/10.1016/j.radonc.2008.02.003
- Lee AWM, Ng WT, Chan OSH, et al (2012). If concurrentadjuvant chemoradiotherapy is beneficial for locoregionally advanced nasopharyngeal carcinoma, would changing the sequence to induction-concurrent achieve better outcome? J Radiat Oncol, 1, 107-15. https://doi.org/10.1007/s13566-012-0032-0
- Liang ZG, Zhu XD, Tan AH, et al (2013). Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma, meta-analysis of 1,096 patients from 11 randomized controlled trials. Asian Pac J Cancer Prev, 14, 515-21. https://doi.org/10.7314/APJCP.2013.14.1.515
- Ma J, Mai HQ, Hong MH, et al (2001). Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol, 19, 1350-1357.
- Oh JL, Vokes EE, Kies MS, et al (2003). Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol, 14, 564. https://doi.org/10.1093/annonc/mdg163
- Phua VCE, Loo WH et al (2013). Treatment outcome for nasopharyngeal carcinoma in University Malaya Medical Centre from 2004-2008. Asian Pac J Cancer Prev, 14, 4567-70 https://doi.org/10.7314/APJCP.2013.14.8.4567
- Rischin D, Corry J, Smith J, et al (2002). Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation. J Clin Oncol, 20, 1845-52. https://doi.org/10.1200/JCO.2002.07.011
- Wee J, Tan EH, Tai BC, et al (2005). Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/international union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol, 23, 6730-8. https://doi.org/10.1200/JCO.2005.16.790
- Yau TK, Lee AW, Wong DH, et al (2006). Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma. Head Neck, 28, 880. https://doi.org/10.1002/hed.20421
피인용 문헌
- Selective Radiotherapy after Distant Metastasis of Nasopharyngeal Carcinoma Treated with Dose-Dense Cisplatin plus Fluorouracil vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.6011